文献速递中毒与环境急症儿科与产科急症

儿童急性探索性锂摄入的结局

Outcomes of acute exploratory pediatric lithium ingestions.
PubMed 文献 · Clin Toxicol (Phila) · 2020-01-08
一句话结论6岁以下儿童急性无意锂摄入严重结局罕见,多数无症状患儿可能无需转诊医院。

该回顾性观察研究查询美国毒物控制中心协会国家毒物数据系统(NPDS),纳入2000至2018年6岁以下儿童单种物质探索性锂盐摄入1863例。中位年龄2岁,51%为男性。医疗结局以无效应和轻微效应为主,184例(10%)报告262项相关临床效应,最常见为呕吐76例、嗜睡/乏力58例、其他22例、共济失调20例。临床效应持续时间≤2小时65例(33%)、2-8小时57例(28.9%)、8-24小时51例(25.9%)、1-3天11例(5.6%)、>3天至≤1周1例(0.5%),无永久性效应,无死亡报告。无患者接受血液透析。由于有剂量信息的中度/重度效应病例太少,无法确定转诊医院的剂量阈值。作者认为大多数无症状6岁以下儿童锂摄入后可能无需转诊医院。

要点

  • 1863例6岁以下儿童探索性锂摄入中,184例(10%)报告相关临床效应,最常见为呕吐76例、嗜睡/乏力58例、共济失调20例。
  • 临床效应持续时间≤2小时者65例(33%)、2-8小时57例(28.9%)、8-24小时51例(25.9%),无永久性效应,无死亡。
  • 管理场所主要为非医疗机构(808例,43.4%),569例(30.5%)在毒物控制中心来电时已在医疗机构,477例(25.6%)被转诊至医疗机构。
  • 最常见处理为稀释(492例)和食物/零食(180例);医疗机构内处理包括静脉输液173例、全肠灌洗46例、单剂活性炭41例、吐根糖浆34例、洗胃31例,无患者接受血液透析。
  • 由于有剂量信息的中度/重度效应病例太少,无法确定转诊医疗机构的剂量阈值。

适用人群与场景

  • 6岁以下儿童单种物质、无意-一般暴露(即探索性摄入)的急性锂盐摄入,2000至2018年报告至美国毒物控制中心协会国家毒物数据系统(NPDS)。

处置流程与药物剂量

  • 最常见处理为稀释(492例)和食物/零食(180例),基本可在家中完成。
  • 医疗机构内处理包括静脉输液173例、其他120例、全肠灌洗46例、单剂活性炭41例、吐根糖浆34例、洗胃31例。
  • 无患者接受血液透析。

研究设计与关键结果

  • 回顾性观察研究,查询NPDS 2000至2018年数据,共3045例单种物质探索性锂摄入,排除1178例后分析1863例。
  • 中位年龄2岁(IQR:1.5,2),51%为男性;摄入途径最常见为经口摄入(1853例,99.5%),暴露场所主要在家(1743例,93.6%)。
  • 医疗结局以无效应和轻微效应为主;184例(10%)报告262项相关临床效应,最常见为呕吐76例、嗜睡/乏力58例、其他22例、共济失调20例。
  • 临床效应持续时间:≤2小时65例(33%)、2-8小时57例(28.9%)、8-24小时51例(25.9%)、1-3天11例(5.6%)、>3天至≤1周1例(0.5%);无永久性效应,无死亡报告。
  • 425例有剂量编码的暴露被毒物控制中心转诊至医疗机构;转诊至医疗机构的剂量随时间无差异(p=0.2747)。
  • 由于有剂量信息的中度/重度效应病例太少,无法确定转诊医疗机构的剂量阈值。

证据类型、等级与局限

  • 证据类型:回顾性观察研究。
  • 局限:由于有剂量信息的中度/重度效应病例太少,无法确定转诊医疗机构的剂量阈值。

对床旁实践的改变

  • 作者认为,大多数无症状6岁以下儿童锂摄入后可能无需转诊医院。
  • 严重结局在儿童无意锂摄入后罕见。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Objectives: To date, very little literature describes the outcomes of acute unintentional ingestions of lithium in young children. This study aimed to describe the clinical effects and outcomes reported in these patients reported to the National Poison Data System (NPDS).Methods: This is a retrospective observational study of acute unintentional lithium ingestions in children <6 years of age. The primary intent of the study was to characterize acute unintentional exposures to lithium in children in this age group. As a secondary outcome, we sought to identify a weight-based threshold to empirically refer patients into a healthcare facility for symptoms consistent with moderate effect or worse. The American Association of Poison Control Centers' NPDS was queried for all acute ingestions of lithium salts in children <6 years of age from 2000 to 2018. Inclusion criteria were single substance ingestions, unintentional-general exposure (i.e., exploratory ingestion), and followed to a known outcome or coded as potentially toxic exposure unable to follow and the patient was experiencing symptoms.Results: A total of 3045 single-substance exploratory ingestions of lithium were reported to poison centers that showed a decrease over time, consistent with decreasing use of lithium and decreasing calls to poison centers. Of the 3045 cases, we excluded 1178 leaving 1863 cases for analysis. Median age was 2 years (IQR: 1.5, 2) with 51% male cases. Management site was primarily non-health care facility (n = 808; 43.4%) with 569 (30.5%) already in a healthcare facility (HCF) when the Poison Control Center (PCC) was called and 477 (25.6%) referred to a HCF. The route of exposure was most commonly ingestion (n = 1853; 99.5%) and site of exposure was primarily home (1743; 93.6%). Medical outcomes were predominantly no effect and minor effect. There were 262 related clinical effects were reported in 184 patients (10%). The most frequently reported were vomiting (n = 76), drowsiness/lethargy (n = 58), other (n = 22), and ataxia (n = 20). Clinical effects lasted ≤2 h for 65 (33%), 2-8 h for 57 (28.9%), 8-24 h for 51 (25.9%), 1-3 days for 11 (5.6%), and >3 days to ≤1 week for 1 (0.5%); no cases resulted in clinical effects thought to be permanent and no deaths were reported. There were 1173 treatments provided to 857 patients. The most common treatments were basic and are readily performed at home; dilution (n = 492) and food/snack (n = 180). A smaller subset of patients received care that could likely only be provided in a healthcare facility including IV fluids (n = 173), other (n = 120), whole bowel irrigation (n = 46), single dose activated charcoal (n = 41), syrup of ipecac (n = 34), and lavage (n = 31). No patients received hemodialysis. A total of 425 of the exposures were referred to a healthcare facility by the PCC which had a dose coded. There was no difference in dose that resulted to referral to a healthcare facility over time (p = 0.2747). Due to the small number of moderate/major effect cases with dose information, we were unable to identify a dose-based threshold for referral to HCF.Conclusions: Severe outcomes after unintentional ingestion of lithium in pediatric patients are rare. It is likely that most asymptomatic pediatric patients <6 years do not need to be referred to the hospital after ingestion of lithium.

来源:Clin Toxicol (Phila),查看原文。版权归原作者所有。

参考来源

  1. Minhaj FS, Anderson BD, King JD, et al. Outcomes of acute exploratory pediatric lithium ingestions. Clin Toxicol (Phila). 2020. PMID: 31913731. doi:10.1080/15563650.2019.1704772

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。